PEG
55
2
CVX
25
2
RL
76
3
REGN
65
2
GS
69
-3
CL
61
-5
LRCX
55
-6
WY
36
5
MAC
71
-4
PSA
48
2
EXC
58
11
ALL
50
2
SIG
79
-2
GOOGL
61
-11
HES
68
2
GOOG
75
2
EA
47
-3
TXT
75
6
NRG
72
-2
CAT
69
3
PEG
55
2
CVX
25
2
RL
76
3
REGN
65
2
GS
69
-3
CL
61
-5
LRCX
55
-6
WY
36
5
MAC
71
-4
PSA
48
2
EXC
58
11
ALL
50
2
SIG
79
-2
GOOGL
61
-11
HES
68
2
GOOG
75
2
EA
47
-3
TXT
75
6
NRG
72
-2
CAT
69
3
Financhill
Back

Spyre Therapeutics Vs. iBio Industry Stock Comparison

Sell
48

SYRE
Spyre Therapeutics

Last Price:
37.77
Seasonality Move:
7.88%
Sell
21

IBIO
iBio

Last Price:
1.98
Seasonality Move:
3.43%
Sell
48
Spyre Therapeutics (SYRE) is a Sell

Is Spyre Therapeutics a Buy, Sell or Hold?

  • The current Spyre Therapeutics [SYRE] share price is $37.80. The Score for SYRE is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
  • SYRE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
21
iBio (IBIO) is a Sell

Is iBio a Buy, Sell or Hold?

  • The current iBio [IBIO] share price is $1.98. The Score for IBIO is 21, which is 58% below its historic median score of 50, and infers higher risk than normal.
  • IBIO is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

SYRE Stock Price Chart

What is Spyre Therapeutics's stock price today?

  • The Spyre Therapeutics share price today is $37.80
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SYRE is experiencing slight buying pressure.

IBIO Stock Price Chart

What is iBio's stock price today?

  • The iBio share price today is $1.98
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and IBIO is experiencing slight buying pressure.

SYRE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.64 Buy
Relative Strength Index (14 RSI): 56 Buy
Chaikin Money Flow: 119333 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (33.32 - 37.1) Buy
Bollinger Bands (100): (23.8 - 38.16) Buy

IBIO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0 Buy
Relative Strength Index (14 RSI): 54.01 Buy
Chaikin Money Flow: 139831 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.76 - 1.96) Buy
Bollinger Bands (100): (0.98 - 2.08) Buy

SYRE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 36.8 Buy
20-day SMA: 35.24 Buy
50-day SMA: 37.04 Buy
200-day SMA: 22.06 Buy
8-day EMA: 37.06 Buy
20-day EMA: 36.15 Buy
50-day EMA: 34.77 Buy
200-day EMA: 25.64 Buy

IBIO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.87 Buy
20-day SMA: 1.86 Buy
50-day SMA: 1.85 Buy
200-day SMA: 3.61 Sell
8-day EMA: 1.89 Buy
20-day EMA: 1.89 Buy
50-day EMA: 1.85 Buy
200-day EMA: 8.18 Sell

Spyre Therapeutics Earnings Growth & SYRE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.10 per share, an increase next quarter of $0.10 per share, an increase this year of $9.41 per share, and an increase next year of $0.45 per share.

iBio Earnings Growth & IBIO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $109.00 per share, and a decrease next year of $0.00 per share.

Spyre Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

iBio Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):